CFGS
DVAX

Concourse Financial Group Securities’s Dynavax Technologies DVAX Stock Holding History

Concourse Financial Group Securities’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$2.32K – 2191
2019
Q4 		$3K Hold
500
– – ﹤0.01% 1758
2019
Q3 		$2K Hold
500
– – ﹤0.01% 1526
2019
Q2 		$2K Hold
500
– – ﹤0.01% 1979
2019
Q1 		$3K Hold
500
– – ﹤0.01% 1911
2018
Q4 		$4K Buy
+500
New +$5.53K ﹤0.01% 1713

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Concourse Financial Group Securities's DVAX Position: Q1 2020 in Review

Concourse Financial Group Securities sold out of Dynavax Technologies (DVAX) in Q1 2020, closing a stake of 500 shares — an estimated $2.32K sold.

Concourse Financial Group Securities first reported a position in DVAX in Q4 2018 and held it in 5 quarters. The position peaked at $4K in Q4 2018. 113 funds tracked by Wall St. Rank hold DVAX as of Q1 2020.

  • Concourse Financial Group Securities reported no remaining Dynavax Technologies position as of Q1 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 500 Dynavax Technologies shares in Q1 2020, an estimated $2.32K.
  • Concourse Financial Group Securities first reported a position in Dynavax Technologies in Q4 2018 and held it in 5 quarters.
  • Concourse Financial Group Securities's Dynavax Technologies position peaked at $4K in Q4 2018.
  • 113 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2020.

Based on Concourse Financial Group Securities's 13F filing for Q1 2020, filed 13 May 2020.